To test the effect of CCL2 on the behavior of HER2/neu-driven mammary carcinomas, we compared the overall survival of mice carrying the MMTV-neu transgene and a targeted deletion of Ccl2 (neu+Ccl2-/-) to mice carrying the MMTV-neu transgene alone (neu+). Here, CCL2 is linked to breast carcinoma.